Elagolix Sodium; NBI 56418NA; NBI-56418 sodium

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
5 mg	3-5days	$120.00	Visible after login	- +
10 mg	3-5days	$160.00	Visible after login	- +

Size

Availability

Price(USD)

VIP Price (USD)

Quantity

5 mg

3-5days

$120.00

Visible after login

- +

10 mg

3-5days

$160.00

Visible after login

- +

Product Overview

Product Name	Elagolix Sodium; NBI 56418NA; NBI-56418 sodium
CAS	832720-36-2
Formula	C32H29F5N3NaO5
MW	653.57
Appearance	White to light yellow powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

Elagolix sodium (NBI56418; ABT-620; Orilissa), the sodium salt of Elagolix, is an orally bioavailable and small molecule antagonist of the gonadotropin-releasing hormone receptor (GnRHR) (KD = 54 pM) approved on 7/23/2018 by FDA for the management of moderate to severe pain associated with endometriosis. Elagolix is a short-acting GnRH antagonist that suppresses ovarian estrogen production in a dose-dependent manner, meaning that higher doses result in full suppression while lower doses only cause partial suppression. Elagolix's non-peptide structure and oral bioavailability make it the leader of a new class of GnRH inhibitors known as second-generation inhibitors.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History